Modular Protein Engineering in Emerging Cancer Therapies

E-ISSN： 1873-4286|15|8|893-916

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.8, 2009-03, pp. : 893-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pancreatic Cancer: A Review of Emerging Therapies

By Rosenberg L.

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1071-1089

Adis International

Access to resources Recommend Favorite

Novel and Emerging Targeted Therapies of Colorectal Cancer

Current Clinical Pharmacology, Vol. 10, Iss. 4, 2015-10 ,pp. : 279-298

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging molecular targeted therapies in the treatment of head and neck cancer

By Bozec Alexandre Peyrade Frédéric Fischel Jean-Louis Milano Gérard

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 299-310

Informa Healthcare

Access to resources Recommend Favorite

Treating systemic prostate cancer: emerging drug targets and therapies

By Gulley J. Arlen P. Dahut W.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 6, 2000-12 ,pp. : 751-763

Informa Healthcare

Access to resources Recommend Favorite

Drugs that Target Lipoxygenases and Leukotrienes as Emerging Therapies for Asthma and Cancer

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 1, 2004-03 ,pp. : 19-33

Bentham Science Publishers

Access to resources Recommend Favorite